Variables | Cases (n = 309)* | Controls (n = 294)* | P-value † |
---|---|---|---|
Age at recruitment | 60.0 (11.8) | 61.4 (13.96) | 0.19 |
Sex: | |||
Men | 160 (51.8) | 161 (54.8) | |
Women | 149 (48.2) | 133 (45.2) | 0.46 |
FH risk***: | |||
Low | 226 (78.7) | 265 (99.6) | |
Medium/High | 61 (21.3) | 1 (0.4) | <0.001 |
Smoking status: | |||
Never | 103 (33.3) | 90 (30.6) | |
Former | 87 (28.2) | 115 (39.4) | |
Current | 41 (13.3) | 45 (15.3) | 0.18 |
Not known | 78 (25.2) | 44 (15.0) | |
Physical activity (cycling & other sport in hours/week) ‡ | |||
0 | 125 (56.6) | 128 (53.6) | |
0.1-3.5 | 56 (25.3) | 65 (27.2) | |
3.6-7 | 23 (10.4) | 24 (10.0) | |
>7 | 17 (7.7) | 22 (9.2) | 0.48 |
BMI‡ ¥: | |||
<25 | 92 (29.8) | 80 (27.2) | |
25-29.9 | 102 (33.0) | 105 (35.7) | |
≥30 | 36 (11.7) | 64 (21.8) | 0.02 |
Unknown | 79 (25.6) | 45 (15.3) | |
Alcohol intake (g/day)‡ | 12.7 (14.6) | 12.9 (13.9) | 0.76 |
Energy intake (kJ/day)‡ | 11016 (3896) | 11054 (4572) | 0.80 |
DEPCAT†† | |||
1 | 33 (10.7) | 33 (11.2) | |
2 | 76 (24.6) | 66 (22.4) | |
3 | 78 (25.2) | 79 (26.9) | |
4 | 69 (22.3) | 66 (22.4) | |
5 | 24 (7.8) | 22 (7.5) | |
6 | 27 (8.7) | 27 (9.2) | |
7 | 2 (0.6) | 1 (0.3) | 0.99 |
PMH Bowel disease (incl. IBS) | 18 (7.8) | 23 (9.3) | 0.56 |
PMH Cancer ± | 24 (10.3) | 13 (5.1) | 0.03 |
Statin use: at least 1 | 25 (8.1) | 44 (15.0) | <0.01 |
prescription dispensed 2/12 | Male: 18 | Male: 31 | Male: <0.05 |
pre-recruitment | Female: 7 | Female: 13 | Female:0.10 |
Statin use: at least | 24 (7.8) | 38 (12.9) | 0.04 |
1prescription dispensed 7/12 | Male: 17 | Male: 28 | Male: 0.08 |
pre-recruitment | Female: 7 | Female: 10 | Female: 0.32 |
Statin use: 2+ prescriptions | 24 (7.8) | 38 (12.9) | 0.04 |
dispensed. First being at least | Male: 17 | Male: 27 | Male: 0.11 |
2/12 pre-recruitment | Female: 7 | Female: 11 | Female: 0.22 |
Statin use: 2+ prescriptions | 23 (7.4) | 34 (11.6) | 0.084 |
dispensed. First prescription at | Male: 16 | Male: 25 | Male: 0.14 |
least 7/12 pre-recruitement | Female: 7 | Female: 9 | Female: 0.45 |
Regular use of NSAIDs**: | |||
Yes | 53 (69.7) | 87 (70.7) | |
No | 165 (17.1) | 146 (17.9) | 0.003 |
Not known | 91 (13.1) | 61 (11.4) | |
HRT use: | |||
Yes | 30 (28.0) | 40 (37.0) | |
No | 76 (71.0) | 68 (63.0) | 0.17 |
Not known | 1 (0.9) | 0 (0) | |
Hormonal contraception use: | |||
Yes | 36 (33.6) | 40 (37.0) | |
No | 70 (65.4) | 67 (62.0) | 0.60 |
Not known | 1 (0.9) | 1 (0.9) |